DLX2 was demonstrated to be associated with EMT in osteosarcoma in previous studies and its increased expression was associated with advanced gastric adenocarcinoma, but no article defining the relationship between DLX2 and poor prognosis in colorectal cancer could be found yet (102, 103). This evidence concerns the gene DLX2 and colorectal cancer.